Efficacy and Safety of Single Dose of 5 mg Zoledronic Acid in Chinese Patients With Paget's Disease of Bone (PDB)
Clinical trial NCT00774020 · COMPLETED
Trial details
- NCT number
- NCT00774020
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-30
- Primary completion
- 2011-01-14
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.